Holdings

Soleus Capital Management, L.P.

As of Sep 30, 2026, Soleus Capital Management, L.P. reported 88 positions worth US$2.58B. Largest: Krystal Biotech, Inc., Insulet Corporation and TG Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Krystal Biotech, Inc.1.14MUS$379M+200KSep 30, 2026
Insulet Corporation1.73MUS$225M+678KSep 30, 2026
TG Therapeutics, Inc.2.56MUS$143M−372KSep 30, 2026
United Therapeutics Corporation259KUS$140M+33,413Sep 30, 2026
Celcuity Inc.1.68MUS$134M−21,558Sep 30, 2026
Rigel Pharmaceuticals, Inc.1.84MUS$88.8Mno changeSep 30, 2026
Inspire Medical Systems, Inc.1.21MUS$83.7M−725KSep 30, 2026
Erasca, Inc.5.11MUS$74.9M+2.41MSep 30, 2026
Beta Bionics, Inc.3.74MUS$71.1M−650KSep 30, 2026
ANI Pharmaceuticals, Inc.976KUS$70.9M+108KSep 30, 2026